Cargando…
Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients
BACKGROUND: In randomized trials (SHARP [Study of Heart and Renal Protection], IMPROVE‐IT [Improved Reduction of Outcomes: Vytorin Efficacy International Trial]), combination of statin and ezetimibe resulted in additional reduction of cardiovascular events. The reduction was greater in patients with...
Autores principales: | Ahmed, Osman, Littmann, Karin, Gustafsson, Ulf, Pramfalk, Camilla, Öörni, Katariina, Larsson, Lilian, Minniti, Mirko E., Sahlin, Staffan, Camejo, German, Parini, Paolo, Eriksson, Mats |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405603/ https://www.ncbi.nlm.nih.gov/pubmed/30561264 http://dx.doi.org/10.1161/JAHA.118.009876 |
Ejemplares similares
-
Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19
por: Ahmed, O., et al.
Publicado: (2021) -
DNA Ploidy and S-Phase Fraction in Carcinoma of the Gallbladder Related to Histopathology, Number of Gallstones and Survival (1)
por: Gustafsson, Ulf, et al.
Publicado: (2001) -
Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
por: Rotella, Carlo M, et al.
Publicado: (2010) -
Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia
por: Visseren, F. L. J.
Publicado: (2011) -
Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient
por: Chanson, Noemie, et al.
Publicado: (2008)